Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2023-04-18 4:15 pm Sale |
2023-04-12 | 13G | Amryt Pharma plc AMYT |
Athyrium Opportunities III Acquisition 2 LP | 0 0.000% |
-44,286,346 (Position Closed) |
Filing History |
| 2023-02-13 10:24 am Purchase |
2022-12-31 | 13G | Amryt Pharma plc AMYT |
Stonepine Capital Management, LLC | 31,666,195 9.900% |
1,317,320 (+4.34%) |
Filing History |
| 2023-02-10 4:00 pm Purchase |
2022-12-31 | 13G | Amryt Pharma plc AMYT |
Rubric Capital Management LP | 18,000,000 5.610% |
277,660 (+1.57%) |
Filing History |
| 2023-02-10 09:48 am Purchase |
2022-12-31 | 13G | Amryt Pharma plc AMYT |
HIGHBRIDGE CAPITAL MANAGEMENT LLC | 31,667,760 9.900% |
4,379,262 (+16.05%) |
Filing History |
| 2022-02-14 10:34 am Sale |
2021-12-31 | 13G | Amryt Pharma plc AMYT |
OCONNOR A Distinct Business Unit of UBS ASSET MANAGEMENT AMERICAS (LLC) | 9,950,000 3.110% |
-3,263,340 (-24.70%) |
Filing History |
| 2022-02-14 08:59 am Purchase |
2021-12-31 | 13G | Amryt Pharma plc AMYT |
Rubric Capital Management LP | 17,722,340 5.590% |
17,722,340 (New Position) |
Filing History |
| 2022-02-11 4:24 pm Unchanged |
2021-12-31 | 13G | Amryt Pharma plc AMYT |
EdgePoint Investment Group Inc. | 0 0.000% |
0 (Unchanged) |
Filing History |
| 2022-02-11 2:27 pm Purchase |
2021-12-31 | 13G | Amryt Pharma plc AMYT |
Stonepine Capital Management, LLC | 30,348,875 9.500% |
19,266,460 (+173.85%) |
Filing History |
| 2022-02-11 08:18 am Purchase |
2021-12-31 | 13G | Amryt Pharma plc AMYT |
HIGHBRIDGE CAPITAL MANAGEMENT LLC | 27,288,498 8.530% |
2,589,665 (+10.48%) |
Filing History |
| 2021-05-05 5:07 pm Unchanged |
2020-12-31 | 13G | Amryt Pharma plc AMYT |
EdgePoint Investment Group Inc. | 0 0.000% |
0 (Unchanged) |
Filing History |
| 2021-02-16 10:32 am Purchase |
2020-12-31 | 13G | Amryt Pharma plc AMYT |
OCONNOR A Distinct Business Unit of UBS ASSET MANAGEMENT AMERICAS (LLC) | 13,213,340 7.300% |
13,213,340 (New Position) |
Filing History |
| 2021-02-12 4:37 pm Purchase |
2020-12-31 | 13G | Amryt Pharma plc AMYT |
Stonepine Capital Management, LLC | 11,082,415 6.200% |
11,082,415 (New Position) |
Filing History |
| 2021-02-12 08:01 am Purchase |
2020-07-08 | 13G | Amryt Pharma plc AMYT |
Athyrium Opportunities III Acquisition 2 LP | 44,286,346 24.800% |
44,286,346 (New Position) |
Filing History |
| 2021-02-05 08:18 am Purchase |
2020-12-31 | 13G | Amryt Pharma plc AMYT |
HIGHBRIDGE CAPITAL MANAGEMENT LLC | 24,698,833 9.990% |
24,698,833 (New Position) |
Filing History |
| 2020-12-22 4:21 pm Purchase |
2020-12-10 | 13G | Amryt Pharma plc AMYT |
STONEPINE CAPITAL L.P. | 11,050,350 6.200% |
11,050,350 (New Position) |
Filing History |